πŸ‡ΊπŸ‡Έ FDA
Patent

US 10960051

Methods of treating dry eye syndrome

granted A61KA61K38/04A61K38/2292

Quick answer

US patent 10960051 (Methods of treating dry eye syndrome) held by REGENTREE, LLC expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENTREE, LLC
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/04, A61K38/2292, A61K47/02, A61K9/0048